Abstract:Maternal PI3K p110δ has been implicated in smaller litter sizes in mice, but its underlying mechanism remains unclear. The placenta is an indispensable chimeric organ that supports mammalian embryonic development. Using a mouse model of genetic inactivation of PI3K p110δ (p110δ D910A/D910A ), we show that fetuses carried by p110δ D910A/D910A females were growth retarded and showed increased mortality in utero mainly during placentation. The placentas in p110δ D910A/D910A females were anomalously anemic, exhibited thinner spongiotrophoblast layer and looser labyrinth zone, which indicate defective placental vasculogenesis. In addition, p110δ was detected in primary trophoblast giant cells (P-TGC) at early placentation. Maternal PI3K p110δ inactivation affected normal TGCs generation and expansion, impeded the branching of chorioallantoic placenta but enhanced the expression of matrix metalloproteinases (MMP-2, MMP-12). Poor vasculature support for the developing fetoplacental unit resulted in fetal death or gross growth retardation. These data, taken together, provide the first in vivo evidence that p110δ may play an important role in placental vascularization through manipulating trophoblast giant cell.

Author Correction: Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse

Phosphoinositide 3-Kinase (Pi3k) Subunit P110 Delta Is Essential For Trophoblast Cell Differentiation And Placental Development In Mouse (Vol 6, 28201, 2016)

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse

Correction: Protein Phosphatase 6 is a Key Factor Regulating Spermatogenesis

Erratum: Myocardium-targeted transplantation of PHD2 shRNA-modified bone mesenchymal stem cells through ultrasound-targeted microbubble destruction protects the heart from acute myocardial infarction: Erratum.

Erratum: Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

Activation of the PI3K/Akt/mTOR/p70S6K Pathway is Involved in S100A4-Induced Viability and Migration in Colorectal Cancer Cells: Erratum

Correction: Corrigendum: Inhibitory Receptors Bind ANGPTLs and Support Blood Stem Cells and Leukaemia Development

Erratum: Angiopoietin-2 induces the neuronal differentiation of mouse embryonic NSCs via phosphatidylinositol 3 kinase-Akt pathway-mediated phosphorylation of mTOR.

Erratum: Alkaline Phosphatase Controls Lineage Switching of Mesenchymal Stem Cells by Regulating the LRP6/GSK3β Complex in Hypophosphatasia: Erratum.

Correction to: C1orf194 deficiency leads to incomplete early embryonic lethality and dominant intermediate Charcot—Marie—Tooth disease in a knockout mouse model

Correction: Transcriptional Effects of E3 Ligase Atrogin-1/MAFbx on Apoptosis, Hypertrophy and Inflammation in Neonatal Rat Cardiomyocytes.

Erratum: Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum.

Correction To: Proto-oncogenes in a Eukaryotic Unicellular Organism Play Essential Roles in Plasmodial Growth in Host Cells

Publisher Correction: Embryonic Defects Induced by Maternal Obesity in Mice Derive from Stella Insufficiency in Oocytes.

Publisher Correction: Role of the BUB3 Protein in Phragmoplast Microtubule Reorganization During Cytokinesis

Corrigendum: Mir-193A-3p Mediates Placenta Accreta Spectrum Development by Targeting EFNB2 Via Epithelial-Mesenchymal Transition Pathway under Decidua Defect Conditions

Corrigendum to “PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling”

Author Correction: PTEN-L is a Novel Protein Phosphatase for Ubiquitin Dephosphorylation to Inhibit PINK1–Parkin-mediated Mitophagy

Publisher Correction: Inflammation-activated CXCL16 pathway contributes to tubulointerstitial injury in mouse diabetic nephropathy